Alcon acquires majority interest in cell therapy company Aurion Biotech, provides operational updates
AURN001 is Aurion Biotech's clinical-stage allogeneic cell therapy asset for corneal oedema secondary to corneal endothelial disease
Internal limiting membrane staining dye ILM-Blue from DORC (Zeiss) receives NMPA approval in China
The approval makes ILM-Blue the first DORC posterior dye product available in China, according to a press release from Zeiss
Association between dry eye, ophthalmic structures and fibromyalgia syndrome
The authors examined vascular and neural structures in the eye, assessing the foveal avascular zone and choroidal thickness
Nanoscope Therapeutics publishes clinical results of MCO-010 findings for patients with retinitis pigmentosa
The synthetic opsin was packaged into an optimised AAV2 gene therapy vector that targets human retinal bipolar cells.
Alcon Clareon Vivity IOL receives CE mark, European commercialisation announced
The lens will be available with the Monarch IV manual delivery system in Q2 and the AutonoMe Automated Pre-Loaded Delivery System in Q3
Moorfields Eye Hospital INSIGHT research hub will collaborate with artificial intelligence development company Insitro
The partnership will use ocular imaging to build an AI foundation model and identify new genetic targets for degenerative diseases
Phase 3 COAST trial fails to meet primary endpoints for wet AMD, Opthea reports
The Combination OPT-302 with Aflibercept Study (COAST) evaluated sozinibercept 2 mg in combination with aflibercept 2 mg for wet age-related macular degeneration
Study examines real-world treat-and-extend outcomes and background factors of macular atrophy
The study demonstrated that the number of injections needed gradually decreased during the follow-up period
Increased paediatric astigmatism prevalence and severity after COVID-19
The study findings indicated that lifestyle changes associated with the COVID-19 pandemic were connected to an increase in childhood astigmatisms
Researchers raise awareness of macular pathologies which mimic AMD and GA
Inherited retinal diseases have disease processes distinct from age-related macular degeneration and geographic atrophy, but may present with "phenocopy" clinical signs
Three researchers receive 2025 ARVO Foundation Early Career Clinician-Scientist Awards
The award recipients are leading research projects in India, Italy and Mexico
Bausch + Lomb launches Arise orthokeratology lens fitting system in Europe, UK and US
The Arise system utilises advanced algorithms to interpret corneal topography images, recommending lenses without requiring a fitting set
EDI-OCT and CVI findings can shed light on choroidal vascular physiology following COVID-19 pneumonia
Investigators measured the choroidal structures using enhanced depth imaging optical coherence tomography
Winterthur, Switzerland welcomes second annual Winterthur Ophthalmology Symposium
After a successful inaugural WOS in 2024, the congress will feature new lectures and wetlabs in its sophomore year
Study assesses efficacy of cyclosporine A 0.1% cationic emulsion drops for postoperative discomfort
Prophylactic cyclosporine A 0.1% eye drops were associated with improved ocular surface homeostasis and reduced inflammation
First patient dosed in Phase 1/2 ASTRA study for Stargardt disease therapy SB-007 (SpliceBio)
SpliceBio continues to actively enroll patients in the ASTRA study and accompanying POLARIS trial
Study links new gender and genetic factors to Fuchs Endothelial Corneal Dystrophy
A large-scale study indicates women are more likely to develop the inherited corneal condition
Her Royal Highness The Duchess of Edinburgh delivers keynote address on gender equity in eye care
The UN Friends of Vision group meeting coincided with International Women's Day and the UN Commission on the Status of Women
Advanced therapies in neovascular AMD and DMO: Experts weigh in
A clinician panel illuminates current treatment paradigms and best practices for reducing treatment burden
OKYO Pharma files US FDA Fast Track application for neuropathic corneal pain treatment urcosimod
Urcosimod, formerly known as OK-101, showed clear statistical significance in multiple endpoints in a recently completed Phase 2 trial
Renal dysfunction negatively impacts effect of diabetic macular oedema therapy
Additionally, the prognosis of macular oedema may help clinicians evaluate renal function, investigators reported
Experts say revakinagene taroretcel-lwey approval may represent dawn of new treatments for neurodegenerative conditions
Clinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2
Nicox SA shares research findings from NCX 470 Mont Blanc Phase 3 glaucoma trial
The novel nitric oxide-donating bimatoprost eye drop is designed to lower IOP in patients with open-angle glaucoma or ocular hypertension
Heidelberg Engineering announces two-day International SPECTRALIS Symposium
The event will include presentations on artificial intelligence, ocular imaging and surgical topics
The Fred Hollows Foundation issues a call to action for International Women's Day
The Australia-based organisation is partnering with the UN Friends of Vision group for an event on 11 March
US FDA approves revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2
The encapsulated cell therapy from Neurotech Pharmaceuticals is the first FDA-approved treatment for MacTel
Comparing postoperative astigmatism following toric IOL implantation VS femtosecond laser-assisted astigmatic keratotomy
The toric IOLs demonstrated a slight advantage over FSAK and were associated with better postoperative uncorrected distance visual acuity
EMA provides positive ATMP opinion for gene therapy products OCU410 and OCU410ST
The modifier gene therapies from Ocugen target geographic atrophy and Stargardt disease
Novel stem cell therapy restores corneal damage previously believed irreversible
The authors said their results provide strong support that cultivated autologous limbal epithelial cell transplantation is safe and feasible
Cognition Therapeutics announces publication reviewing potential of zervimesine (CT1812) in dry AMD
One in vitro study included in the manuscript was conducted in collaboration with researchers at the University of Southhampton in the United Kingdom
